Briefing | Pharmaceuticals

Billion dollar pills

An overhaul at Pfizer, the biggest and most conservative of drugs firms, shows what ails the industry

|new york

“DEATH is optional,” says a smiling David Brennan. As an American, he is only half joking about his homeland's demands for a cure for everything. But as chief executive of AstraZeneca, a big British drugs firm, his brimming self-confidence is a reminder of the genuine long-term promise of the pharmaceuticals industry. The world will always need health care—and more and more of it as developed countries grow older and developing nations grow richer. The demand for new drugs can only increase.

This article appeared in the Briefing section of the print edition under the headline “Billion dollar pills”

The greening of America

From the January 27th 2007 edition

Discover stories from this section and more in the list of contents

Explore the edition

Discover more

The Adani bribery case could upend Indian business and politics

The allegations against the corporate champion may end up being resolved diplomatically rather than in court

The war in Ukraine is straining Russia’s economy and society

Despite advances on the battlefield, pressure is growing


View of the snow-covered Kyiv Pechersk Lavra, Kyiv, Ukraine

How will Donald Trump handle the war in Ukraine?

And how will Ukraine, Russia and Europe respond?


Elon Musk’s transformation, in his own words

Our analysis of 38,000 posts on X reveal a changed man

The energy transition will be much cheaper than you think

Most analysts overestimate energy demand and underestimate technological advances